For research and educational purposes only. Not medical advice.
Goralatide Reference
Educational, not medical advice reference for Goralatide: Recovery, Longevity; regulatory status, evidence posture, source review, and schedule notes. Also k…
Reference summary
Published work is mostly preclinical, focused on antifibrotic activity in cardiac, pulmonary, and renal models. Clinical antifibrotic programs have been small and exploratory.
- Categories
- Recovery, Longevity
- Aliases
- Ac-SDKP, N-acetyl-Seryl-Aspartyl-Lysyl-Proline
- Evidence posture
- preclinical — Mostly rodent antifibrotic data. Human clinical antifibrotic programs are exploratory and small. No FDA-approved indication.
- Regulatory status
- No FDA-approved Ac-SDKP / goralatide drug label. Ac-SDKP is the natural N-terminal tetrapeptide cleaved from thymosin beta-4 and has been studied as an antifibrotic and hematopoietic regulator.
- Content review status
- research reference